These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 37417244

  • 1. Antenatal thiopurine exposure in women with IBD is associated with intrahepatic cholestasis of pregnancy.
    Selinger CP, Rosiou K, Broglio G, Lever G, Chiu CM, Stocker LJ, Chipeta H, Glanville T.
    Expert Opin Drug Saf; 2023; 22(11):1091-1097. PubMed ID: 37417244
    [Abstract] [Full Text] [Related]

  • 2. Thiopurine Metabolite Shunting in Late Pregnancy Increases the Risk of Intrahepatic Cholestasis of Pregnancy in Women With Inflammatory Bowel Disease, and Can be Managed With Split Dosing.
    Prentice R, Flanagan E, Wright E, Prideaux L, Connell W, Sparrow M, De Cruz P, Lust M, Hardikar W, Goldberg R, Vogrin S, Palmer K, Ross A, Burns M, Greeve T, Bell S.
    J Crohns Colitis; 2024 Aug 06; 18(7):1081-1090. PubMed ID: 38366352
    [Abstract] [Full Text] [Related]

  • 3. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease.
    Akbari M, Shah S, Velayos FS, Mahadevan U, Cheifetz AS.
    Inflamm Bowel Dis; 2013 Jan 06; 19(1):15-22. PubMed ID: 22434610
    [Abstract] [Full Text] [Related]

  • 4. Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.
    Gómez-García M, Cabello-Tapia MJ, Sánchez-Capilla AD, De Teresa-Galván J, Redondo-Cerezo E.
    World J Gastroenterol; 2013 Aug 14; 19(30):4877-86. PubMed ID: 23946592
    [Abstract] [Full Text] [Related]

  • 5. Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study.
    Setshedi M, Epstein D, Winter TA, Myer L, Watermeyer G, Hift R.
    J Gastroenterol Hepatol; 2012 Feb 14; 27(2):385-9. PubMed ID: 21793904
    [Abstract] [Full Text] [Related]

  • 6. The risk of non-melanoma skin cancer in New Zealand in inflammatory bowel disease patients treated with thiopurines.
    Bahi M, Walmsley RS, Gray AR, Young D, Hobbs CE, Aluzaite K, Schultz M.
    J Gastroenterol Hepatol; 2018 May 14; 33(5):1047-1052. PubMed ID: 29105142
    [Abstract] [Full Text] [Related]

  • 7. Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease.
    Barnes A, Ooi SJ, Lynch KD, Parthasarathy N, Bishara M, Gounder M, Grafton R, Leach P, Bampton P, Sechi A, Ng W, Connor S, van Langenberg D, Mountifield R, Andrews JM.
    Dig Dis Sci; 2023 Mar 14; 68(3):889-896. PubMed ID: 35687221
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased risk of thiopurine-related adverse events in elderly patients with IBD.
    Calafat M, Mañosa M, Cañete F, Ricart E, Iglesias E, Calvo M, Rodríguez-Moranta F, Taxonera C, Nos P, Mesonero F, Martín-Arranz MD, Mínguez M, Gisbert JP, García-López S, de Francisco R, Gomollón F, Calvet X, Garcia-Planella E, Rivero M, Martínez-Cadilla J, Argüelles F, Arias L, Cimavilla M, Zabana Y, Domènech E, ENEIDA registry of GETECCU.
    Aliment Pharmacol Ther; 2019 Oct 14; 50(7):780-788. PubMed ID: 31429097
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.
    Jharap B, de Boer NK, Stokkers P, Hommes DW, Oldenburg B, Dijkstra G, van der Woude CJ, de Jong DJ, Mulder CJ, van Elburg RM, van Bodegraven AA, Dutch Initiative on Crohn and Colitis.
    Gut; 2014 Mar 14; 63(3):451-7. PubMed ID: 23424097
    [Abstract] [Full Text] [Related]

  • 12. NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD.
    Kakuta Y, Naito T, Onodera M, Kuroha M, Kimura T, Shiga H, Endo K, Negoro K, Kinouchi Y, Shimosegawa T.
    Pharmacogenomics J; 2016 Jun 14; 16(3):280-5. PubMed ID: 26076924
    [Abstract] [Full Text] [Related]

  • 13. Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy.
    Jansen FM, Smits LJT, Thomas PWA, de Jong DJ, Kreijne JE, van Dop WA, den Broeder N, Hoentjen F.
    Dig Dis Sci; 2023 Jul 14; 68(7):2936-2945. PubMed ID: 37131100
    [Abstract] [Full Text] [Related]

  • 14. Thiopurine Therapy for Inflammatory Bowel Disease During Pregnancy Is Not Associated with Anemia in the Infant.
    Koslowsky B, Sadeh C, Grisaru-Granovsky S, Miskin H, Goldin E, Bar-Gil Shitrit A.
    Dig Dis Sci; 2019 Aug 14; 64(8):2286-2290. PubMed ID: 30815823
    [Abstract] [Full Text] [Related]

  • 15. Association between Thiopurines Use and Pregnancy Outcomes in Female Patients with Inflammatory Bowel Disease: A Meta-Analysis.
    Zhang Y, Li D, Guo H, Wang W, Li X, Shen S.
    Curr Pharm Des; 2021 Aug 14; 27(19):2317-2324. PubMed ID: 32938343
    [Abstract] [Full Text] [Related]

  • 16. Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines.
    Teruel C, López-San Román A, Bermejo F, Taxonera C, Pérez-Calle JL, Gisbert JP, Martín-Arranz M, Ponferrada A, Van Domselaar M, Algaba A, Estellés J, López-Serrano P, Linares PM, Muriel A.
    Am J Gastroenterol; 2010 Sep 14; 105(9):2003-8. PubMed ID: 20700117
    [Abstract] [Full Text] [Related]

  • 17. Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis.
    Mozaffari S, Abdolghaffari AH, Nikfar S, Abdollahi M.
    Hum Exp Toxicol; 2015 May 14; 34(5):445-59. PubMed ID: 25378092
    [Abstract] [Full Text] [Related]

  • 18. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.
    Teml A, Schaeffeler E, Herrlinger KR, Klotz U, Schwab M.
    Clin Pharmacokinet; 2007 May 14; 46(3):187-208. PubMed ID: 17328579
    [Abstract] [Full Text] [Related]

  • 19. Lack of Increased Risk of Lymphoma with Thiopurine Therapy Regardless of Dose and Duration of Treatment in Japanese Patients with Inflammatory Bowel Diseases.
    Kobayashi T, Udagawa E, Hibi T.
    Digestion; 2022 May 14; 103(2):169-173. PubMed ID: 34983046
    [Abstract] [Full Text] [Related]

  • 20. The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy.
    Hutson JR, Matlow JN, Moretti ME, Koren G.
    J Obstet Gynaecol; 2013 Jan 14; 33(1):1-8. PubMed ID: 23259868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.